Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Clinical trial NCT00014170 · COMPLETED

Trial details

NCT number: NCT00014170
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma

Start date: 2001-03-01
Primary completion: 2003-07-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.